Cumberland Pharmaceuticals
CPIX
27 hedge funds and large institutions have $30.5M invested in Cumberland Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $30.6M → $30.5M (-$91K)
2.3% less ownership
Funds ownership: 34.41% → 32.11% (-2.3%)
18% less funds holding
Funds holding: 33 → 27 (-6)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$569K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.4K |
| 3 |
SEI Investments
Oaks,
Pennsylvania
|
+$3.43K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$1.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
New York State Common Retirement Fund
Albany,
New York
|
-$1.49M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
-$661K |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$170K |
| 4 |
State Street
Boston,
Massachusetts
|
-$81K |
| 5 |
SIM
Spark Investment Management
New York
|
-$61K |
CPIX Hedge Fund Activity: Q4 2018 in Review
27 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2018, worth a combined $30.5M — down 0.3% from $30.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CPIX and 1 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 4 added.
The largest buyer was Stonepine Capital Management, adding an estimated $569K. The largest seller was New York State Common Retirement Fund, exiting entirely with an estimated $1.49M sold.
- 27 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2018, down from 33 in Q3 2018.
- Funds reported $30.5M of Cumberland Pharmaceuticals stock for Q4 2018, down 0.3% quarter-over-quarter.
- 1 fund opened new Cumberland Pharmaceuticals positions in Q4 2018 and 7 closed out, a net change of -6 holders.
- The largest Cumberland Pharmaceuticals buyer in Q4 2018 was Stonepine Capital Management, an estimated $569K added.
- The largest Cumberland Pharmaceuticals seller in Q4 2018 was New York State Common Retirement Fund, an estimated $1.49M sold.
Based on aggregated 13F filings for Q4 2018.